Company Search:
Advanced Search
Sponsored Links
Indofarma (Persero) Tbk PT Company Snapshot
Indofarma (Persero) Tbk PT operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Indofarma (Persero) Tbk PT with three other pharmaceutical manufacturers in Asia: Changzhou Qianhong Biopharma Co., Ltd. of China (2016 sales of 776.38 million Chinese Renmimbi [US$122.30 million] of which 100% was Bio-pharmaceutical Industry), JW Life Science Corp of South Korea (132.29 billion Korean Won [US$123.56 million] ), and Dawnrays Pharmaceutical (Holdings) Ltd which is based in Hong Kong (961.65 million Hong Kong Dollars [US$122.93 million] of which 80% was Finished Drugs).

Sales Analysis. During the year ended December of 2016, sales at Indofarma (Persero) Tbk PT were 1.67 trillion Indonesian Rupiahs (US$122.92 million). This is an increase of 3.3% versus 2015, when the company's sales were 1.62 trillion Indonesian Rupiahs. This was the fourth straight year of sales growth at Indofarma (Persero) Tbk PT.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Indofarma (Persero) Tbk PT
  Stock Performance Chart for Indofarma (Persero) Tbk PT
  Stock Data: Recent Stock Performance:
  Current Price (2/15/2018): 4,520.00
(Figures in Indonesian Rupiahs)
1 Week 2.3%   13 Weeks 3.0%  
4 Weeks 76.6%   52 Weeks 86.8%  
Indofarma (Persero) Tbk PT Key Data:
  Ticker: INAF Country: Indonesia
  Exchanges: JAK Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 1,674,702,722,328
(Year Ending Jan 2017).
Employees: 1,758
  Currency: Indonesian Rupiahs Market Cap: 14,008,689,100,000
  Fiscal Yr Ends: December Shares Outstanding: 3,099,267,500
  Share Type: Ordinary Closely Held Shares: 2,500,000,000
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.